Literature DB >> 20424502

Non-verbal behaviour of patients with schizophrenia in medical consultations--a comparison with depressed patients and association with symptom levels.

Sara Dimic1, Christiane Wildgrube, Rosemarie McCabe, Imren Hassan, Thomas R E Barnes, Stefan Priebe.   

Abstract

BACKGROUND: The Dutch psychiatrist Rümke introduced the notion that patients with schizophrenia could be recognised intuitively by an experienced psychiatrist, naming the process as the 'praecox feeling'. This feeling may reflect aspects of the non-verbal behaviour of patients as shown in a medical consultation. The aim of this study was to test whether aspects of the initial non-verbal behaviour of patients with schizophrenia and depression in medical consultations differ and are associated with symptom levels in each group. SAMPLING AND
METHOD: The first 2 min of videotaped outpatient consultations with 78 patients (39 each with schizophrenia and depression) were analysed by researchers who were masked to the diagnosis and symptom levels of the patients. Non-verbal behaviour was assessed using a modified Ethological Coding System for Interviews. Symptom levels were rated by independent researchers on the Positive and Negative Syndrome Scale and Beck Depression Inventory.
RESULTS: The 2 diagnostic groups showed significant differences on 1 out of 6 aspects of non-verbal communication, with patients with schizophrenia exhibiting more 'flight' behaviour, i.e. more looking down or away, crouching and freezing. Within the group of patients with schizophrenia, more 'flight' and less 'assertion' were associated with higher symptom levels.
CONCLUSION: Initial 'flight' behaviour of patients in medical consultations may be specific for schizophrenia and associated with the symptoms of that illness. Such behaviour might indicate an avoidance of potentially adverse communication, and future research should investigate whether it can also be identified in everyday social interactions other than medical consultations. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20424502     DOI: 10.1159/000313519

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  8 in total

Review 1.  Reassessing "Praecox Feeling" in Diagnostic Decision Making in Schizophrenia: A Critical Review.

Authors:  Tudi Gozé; Marcin Moskalewicz; Michael A Schwartz; Jean Naudin; Jean-Arthur Micoulaud-Franchi; Michel Cermolacce
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

2.  The assessment of nonverbal behavior in schizophrenia through the Formal Psychological Assessment.

Authors:  Umberto Granziol; Andrea Spoto; Giulio Vidotto
Journal:  Int J Methods Psychiatr Res       Date:  2017-11-03       Impact factor: 4.035

3.  Using video-annotation software to identify interactions in group therapies for schizophrenia: assessing reliability and associations with outcomes.

Authors:  Stavros Orfanos; Syeda Ferhana Akther; Muhammad Abdul-Basit; Rosemarie McCabe; Stefan Priebe
Journal:  BMC Psychiatry       Date:  2017-02-10       Impact factor: 3.630

4.  Ward round competences in surgery and psychiatry - a comparative multidisciplinary interview study.

Authors:  Elisa Vietz; Esther März; Christian Lottspeich; Teresa Wölfel; Martin R Fischer; Ralf Schmidmaier
Journal:  BMC Med Educ       Date:  2019-05-08       Impact factor: 2.463

5.  Identifying Psychological Symptoms Based on Facial Movements.

Authors:  Xiaoyang Wang; Yilin Wang; Mingjie Zhou; Baobin Li; Xiaoqian Liu; Tingshao Zhu
Journal:  Front Psychiatry       Date:  2020-12-15       Impact factor: 4.157

6.  Hand gesture performance is impaired in major depressive disorder: A matter of working memory performance?

Authors:  Anastasia Pavlidou; Petra V Viher; Hanta Bachofner; Florian Weiss; Katharina Stegmayer; Stewart A Shankman; Vijay A Mittal; Sebastian Walther
Journal:  J Affect Disord       Date:  2021-05-28       Impact factor: 6.533

7.  Participation during first social encounters in schizophrenia.

Authors:  Mary Lavelle; Patrick G T Healey; Rosemarie McCabe
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

8.  A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Authors:  Eva A Malt; Katalin Juhasz; Ulrik F Malt; Thomas Naumann
Journal:  Front Behav Neurosci       Date:  2016-03-30       Impact factor: 3.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.